Andrew D Hershey
Overview
Explore the profile of Andrew D Hershey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
1865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hershey A, Shmuely S, Stark-Inbar A, Asmar Y, Ironi A, Strong E, et al.
Children (Basel)
. 2024 Nov;
11(11).
PMID: 39594861
Migraine affects 10% of adolescents and children. Typical school protocols in the USA require pharmacological medications to be administered by school nurses, often resulting in treatment delays or omissions when...
2.
Murphy C, Ladak A, Szperka C, Marquez De Prado B, Hershey A, Gentile C
Headache
. 2024 Nov;
65(3):420-429.
PMID: 39545632
Objective: To explore the relationships among anxiety, depression, and headache-related disability in a pediatric clinic-based retrospective cross-sectional study. Background: Anxiety and depression are commonly considered comorbidities of headache disorders and...
3.
Noser A, Robbertz A, Peugh J, Kabbouche M, Kacperski J, Powers S, et al.
Pain Med
. 2024 Nov;
26(3):170-172.
PMID: 39499158
No abstract available.
4.
Gentile C, Szperka C, Hershey A
Headache
. 2024 Oct;
64(10):1230-1243.
PMID: 39463035
Objective: To conduct a retrospective cross-sectional multicenter study to validate the relationships between migraine-associated symptoms. Background: Symptoms associated with headache-photophobia and phonophobia, nausea, and/or vomiting-are required criteria for migraine diagnosis...
5.
Gentile C, Hershey A, Szperka C
Headache
. 2024 Oct;
64(10):1217-1229.
PMID: 39463026
Objectives: We used Cluster Analysis of Migraine-associated Symptoms (CAMS) to critically evaluate current International Classification of Headache Disorders-Third Edition (ICHD-3) migraine-associated symptoms criteria. Background: Diagnostic criteria play a central role...
6.
Szperka C, Evans M, Gentile C, Panigrahi P, Raj N, Marquez De Prado B, et al.
Cephalalgia
. 2024 Oct;
44(10):3331024241282803.
PMID: 39370854
Background: New daily persistent headache (NDPH) is a challenging and understudied primary headache disorder with no known effective treatment. Although the International Classification of Headache Disorders criteria require that the...
7.
Orr S, Kuziek J, Ali S, Anderson E, Birnie K, Hershey A, et al.
Headache
. 2024 Sep;
PMID: 39290050
Objective: Using a double-dummy pilot randomized controlled trial design, we aimed to determine the feasibility and acceptability of comparing remote electrical neuromodulation (REN) to typical care intravenous pharmacologic interventions for...
8.
Lindsay R, Kalifa A, Kuziek J, Kabbouche M, Hershey A, Orr S
Headache
. 2024 Aug;
64(10):1200-1216.
PMID: 39129275
Objective: To qualitatively and quantitatively summarize the evidence for the use of onabotulinumtoxinA injections in children and adolescents with migraine. Background: There are limited evidence-based treatment options for youth with...
9.
Vives-Mestres M, Casanova A, Silberstein S, Hershey A, Orr S
Headache
. 2024 Jun;
64(8):995-1004.
PMID: 38932610
Objective: To describe the association between day-to-day peak pain severity and clinical factors in individuals with chronic migraine (CM). Background: Little is known about how clinical factors relate to day-to-day...
10.
Cho L, Bell T, Craddock L, Godfrey K, Hershey A, Kuziek J, et al.
Pain
. 2024 Jun;
165(12):2749-2761.
PMID: 38833578
In patients with migraine, an excitation-inhibition imbalance that fluctuates relative to attack onset has been proposed to contribute to the underlying pathophysiology of migraine, but this has yet to be...